4 latest FDA approvals

Here are the four latest drugs or medical devices approved by the Food and Drug Administration this week.

1. Vosevi is a follow-up treatment for adults with chronic hepatitis C virus genotypes 1 through 6 who have mild or no cirrhosis.

2. Nerlynx is a treatment for early-stage breast cancer patients with a HER2 genetic mutation.

3. Lusdana Nexvue is a biosimilar version of Sanofi's diabetes drug Lantus.

4. The Embrace Neonatal MRI System is an MRI device for infants in the neonatal intensive care unit.

More articles on supply chain:

5 steps to reduce blood costs at your hospital
Bloomberg: FedEx's TNT 'may never fully recover' from Petya attack
5 must-reads for supply chain leaders this week

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars